Balfour D J
Department of Pharmacology and Clinical Pharmacology, University of Dundee Medical School, Ninewells Hospital, UK.
Addiction. 1994 Nov;89(11):1419-23. doi: 10.1111/j.1360-0443.1994.tb03738.x.
There is little doubt that many habitual smokers find it difficult to quit the habit because they have become addicted to the nicotine present in the smoke. This paper addresses some of the pharmacological mechanisms underlying this addiction and discusses how an understanding of these mechanisms may contribute to the more effective use of nicotine replacement therapy during smoking cessation. It considers critically the evidence that the "rewarding" properties of nicotine, which serve to reinforce drug-seeking behaviour, are related to stimulation of the mesolimbic dopamine system of the brain. The critique focuses specifically on the evidence that many central nicotinic receptors, including those which mediate the effects of the drug on dopamine secretion, are readily desensitized by chronic exposure to agonist and that hypotheses which assume that nicotine inhaled from tobacco smoke invariably results in stimulation of the receptors must be treated with caution. Nicotinic receptors in the brain are, however, heterogeneous in nature with different molecular structures and pharmacologies. It is concluded that the reinforcing properties of nicotine sought by smokers may reflect both stimulation and desensitization of the different nicotinic receptor populations, and that smokers may adjust their smoking habits to achieve the balance of receptor stimulation and desensitization which they find most reinforcing. It seems likely that the efficacy of the different nicotine formulations during the treatment of smoking cessation may also reflect their ability to stimulate or desensitize brain nicotinic receptors.
毫无疑问,许多习惯性吸烟者发现很难戒掉吸烟的习惯,因为他们已经对烟雾中的尼古丁上瘾。本文阐述了这种成瘾背后的一些药理学机制,并讨论了对这些机制的理解如何有助于在戒烟过程中更有效地使用尼古丁替代疗法。本文批判性地审视了这样的证据:尼古丁的“奖赏”特性(用于强化寻求药物的行为)与刺激大脑中脑边缘多巴胺系统有关。这种批判性审视特别关注以下证据:许多中枢烟碱受体,包括那些介导药物对多巴胺分泌作用的受体,会因长期暴露于激动剂而容易脱敏,因此,那些认为从烟草烟雾中吸入的尼古丁总会刺激这些受体的假设必须谨慎对待。然而,大脑中的烟碱受体在本质上是异质性的,具有不同的分子结构和药理学特性。得出的结论是,吸烟者所追求的尼古丁的强化特性可能既反映了不同烟碱受体群体的刺激,也反映了它们的脱敏,而且吸烟者可能会调整他们的吸烟习惯,以实现他们认为最具强化作用的受体刺激和脱敏的平衡。不同尼古丁制剂在戒烟治疗中的疗效似乎也可能反映了它们刺激或使大脑烟碱受体脱敏的能力。